Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study

The use of metformin in chronic kidney disease (CKD) population has been intensely debated with conflicting evidence. Large population studies are needed to inform risk assessment and therapeutic decision-making. We evaluated the associations among metformin, metabolic acidosis, and CKD in a 10-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Chin-Chi, Yeh, Hung-Chieh, Chen, Bradley, Tsai, Ching-Wei, Lin, Yu-Sheng, Huang, Chiu-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697969/
https://www.ncbi.nlm.nih.gov/pubmed/26705203
http://dx.doi.org/10.1097/MD.0000000000002175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697969/
https://www.ncbi.nlm.nih.gov/pubmed/26705203
http://dx.doi.org/10.1097/MD.0000000000002175

Ejemplares similares